AstraZeneca Pharma India Limited (NSE: ASTRAZEN)
India flag India · Delayed Price · Currency is INR
6,423.20
-34.25 (-0.53%)
Dec 24, 2024, 3:29 PM IST

AstraZeneca Pharma India Income Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20 2019 - 2015
Revenue
14,84512,95510,0308,0568,1368,318
Upgrade
Revenue Growth (YoY)
30.10%29.17%24.50%-0.98%-2.19%14.21%
Upgrade
Cost of Revenue
8,2446,0083,6603,1693,0103,116
Upgrade
Gross Profit
6,6016,9476,3704,8875,1255,202
Upgrade
Selling, General & Admin
2,5432,4192,5912,3032,1992,180
Upgrade
Other Operating Expenses
2,4292,6102,1111,6791,5391,795
Upgrade
Operating Expenses
5,2385,2334,8814,1933,9634,176
Upgrade
Operating Income
1,3631,7141,489693.61,1631,026
Upgrade
Interest Expense
-10-12-6.3-9.5-10.9-11.4
Upgrade
Interest & Investment Income
325.7325.7231.2114.8104.6122.3
Upgrade
Currency Exchange Gain (Loss)
-5-52.8-1.3-5.4-4.4
Upgrade
Other Non Operating Income (Expenses)
20.520.22.14.62.14.7
Upgrade
EBT Excluding Unusual Items
1,6942,0431,718802.21,2531,137
Upgrade
Merger & Restructuring Charges
-575.6--211.3---
Upgrade
Gain (Loss) on Sale of Assets
0.30.324.928.221.72.9
Upgrade
Asset Writedown
-12.4-12.4---3.8-
Upgrade
Other Unusual Items
-164.3-191---
Upgrade
Pretax Income
1,1062,1951,341830.41,2711,140
Upgrade
Income Tax Expense
287.1580.3348.1214.4337.9417.6
Upgrade
Net Income
819.21,615992.9616933722.1
Upgrade
Net Income to Common
819.21,615992.9616933722.1
Upgrade
Net Income Growth
-46.39%62.66%61.19%-33.98%29.21%32.62%
Upgrade
Shares Outstanding (Basic)
252525252525
Upgrade
Shares Outstanding (Diluted)
252525252525
Upgrade
Shares Change (YoY)
-0.03%-----
Upgrade
EPS (Basic)
32.7764.6039.7224.6437.3228.88
Upgrade
EPS (Diluted)
32.7764.6039.7224.6437.3228.88
Upgrade
EPS Growth
-46.37%62.66%61.19%-33.98%29.21%32.62%
Upgrade
Free Cash Flow
83.2171.1497.7911.8970.7732
Upgrade
Free Cash Flow Per Share
3.336.8419.9136.4738.8329.28
Upgrade
Dividend Per Share
-24.00016.00010.0002.0001.000
Upgrade
Dividend Growth
-50.00%60.00%400.00%100.00%-
Upgrade
Gross Margin
44.46%53.63%63.51%60.66%63.00%62.53%
Upgrade
Operating Margin
9.18%13.23%14.84%8.61%14.29%12.33%
Upgrade
Profit Margin
5.52%12.47%9.90%7.65%11.47%8.68%
Upgrade
Free Cash Flow Margin
0.56%1.32%4.96%11.32%11.93%8.80%
Upgrade
EBITDA
1,5381,8321,613826.71,3261,180
Upgrade
EBITDA Margin
10.36%14.14%16.09%10.26%16.30%14.18%
Upgrade
D&A For EBITDA
174.8117.2124.7133.1163.6154.2
Upgrade
EBIT
1,3631,7141,489693.61,1631,026
Upgrade
EBIT Margin
9.18%13.23%14.84%8.61%14.29%12.33%
Upgrade
Effective Tax Rate
25.95%26.43%25.96%25.82%26.59%36.64%
Upgrade
Revenue as Reported
15,19313,30310,2918,2048,2648,448
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.